June 19, 2018 Once-daily oral baricitinib 4 mg was associated with significant clinical improvements compared with placebo in patients with systemic lupus erythematosus (SLE) receiving standard background therapy, according to data presented at the European League Against Rheumatism (EULAR) Congress held in Amsterdam, June 13 to 16, 2018…. A significantly greater percentage of patients in the […] READ MORE
2018 Lupus Insight Prize Presented to Dr. Betty Diamond Funds Study of Common Hypertension Drugs to Treat Lupus June 21, 2018 The Lupus Research Alliance has awarded its 2018 Lupus Insight Prize to Betty Diamond, MD, for a project to test commonly used drugs for high blood pressure as potential treatments for cognitive and emotional […] READ MORE
June 13, 2018 Our advocates knocked on Capitol doors in March with requests to robustly fund the Lupus Research Program first established last year within the Defense Department’s Congressionally Directed Medical Research Programs. And our nation’s legislators listened! As a result of advocacy by lupus patients, organizations like the Lupus Research Alliance and supportive Members […] READ MORE
June 5, 2018 The Lupus Research Alliance is driven by one central goal — to improve the lives of people living with the disease, today and in the long term. We believe that scientific research is the most powerful way we can achieve this goal. Further, we believe that by both pushing the limits of scientific exploration and […] READ MORE
June 1, 2018 Feinstein Institute for Medical Research Professor Betty Diamond, MD, and colleagues discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood. Health care professionals could now feasibly use these markers to anticipate which lupus patients might benefit from early […] READ MORE
May 31, 2018 Member of Lupus Research Alliance Young Leaders group, lupus spokesperson, blogger and champion Shanelle Gabriel shares her experience living with lupus from diagnosis to day-to-day management. Her main message –people of color are under-represented in clinical trials and need to participate so that new treatments can be tested among the people who […] READ MORE
2018 Handbag Luncheon Honors PUMA for Selena Gomez Lupus Campaign NEW YORK, NY – May 22, 2018. The 9th annual Lupus Research Alliance Lupus Handbag Luncheon & Silent Auction honored two stand-out supporters to the lupus cause: world-leading sports brand PUMA and IBM Associate Partner Veronica Vargas Lupo. PUMA was named “Corporate Visionary Partner” in […] READ MORE
Our Advocacy Success: First Awardees Announced for Department of Defense Lupus Research Program May 17, 2018 The Lupus Research Program (LRP) that was established in 2017 because of our advocates’ hard work is a triumph for scientific exploration in lupus. Over 120 applications from top lupus researchers were received and 13 were […] READ MORE
Kudos to Board Member Nadeem Meghji May 9, 2018 Congratulations to Lupus Research Alliance Board member Nadeem Meghji for being chosen to join the World Economic Forum’s community of Young Global Leaders! Mr. Meghji is among 100 of the world’s most promising artists, business leaders, public servants, technologists and social entrepreneurs comprising this prestigious group. In […] READ MORE
Advancing Lupus Care Through Research and Advocacy: The Progress and the Promise August 11, 2018 11:00 AM – 2:00 PM The Franklin Institute Levitt & Gershman Conference Center 222 N. 20th Street Philadelphia, Pennsylvania 19103 How Can Lupus Research Transform Lives? Find Out at our Free Conference! Confirmed speakers include experts […] READ MORE
Welcome to Lupus Awareness Month The Lupus Research Alliance celebrates the strength, passion and optimism that marks people with lupus and those who love them this May. As we share the extraordinary stories of four lupus warriors over the next few weeks, we want to hear all of your stories. Each […] READ MORE
April 26, 2018 Lupus Research Alliance and Lupus Therapeutics collaborate with Bristol-Myers Squibb on a New Lupus Trial The Lupus Research Alliance today announced a collaboration between its newly formed affiliate, Lupus Therapeutics, and the pharmaceutical company, Bristol-Myers Squibb (BMS), to test a novel investigational drug, BMS-986165, as a potential new therapy for lupus. The […] READ MORE
